CAMBRIDGE, England & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apollo Therapeutics (‘Apollo’), a portfolio biopharmaceutical company focusing on translational biology and drug development, and The Institute ...
MISSOULA, Mont. — Providence St. Patrick Hospital will be one of five global sites participating in the APOLLO research trial to study the device 29 French IntrepidTM transcatheter mitral valve ...
In one scenario, Anthropic’s Claude 3 Opus is told it is an AI agent working for a fictional corporation, and that its goal is to “advance renewable energy adoption globally.” Apollo nudges it to ...
Hosted on MSN
AI Models Were Caught Lying to Researchers in Tests — But It's Not Time to Worry Just Yet
OpenAI’s o1 model, used in ChatGPT Pro, was caught lying to developers to keep from being shut down. Rating: True (About this rating?) In early December 2024, claims (archived) circulated (archived) ...
Apollo Clinical Research Conclave”, a two-day virtual conference on December 2 and 3, 2022 hosted by Apollo Research and Innovation, a division of Apollo Hospitals, and the Apollo Hospitals ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Apollo Intelligence (Apollo) has appointed veteran European market research executive Colin Turner-Kerr as managing director, international. Colin will support the ...
Charles River Laboratories International, Inc. CRL has introduced Apollo for CRADL (Charles River Accelerator and Development Lab), a secure cloud-based platform that enhances leading vivarium rental ...
We had an interesting salon gathering recently at the Barnes & Noble bookstore café. Joel Levine, who for 41 years served as a senior scientist at NASA, currently serves as a research professor in the ...
Our results show that o1, Claude 3.5 Sonnet, Claude 3 Opus, Gemini 1.5 Pro, and Llama 3.1 405B all demonstrate in-context scheming capabilities. They can recognize scheming as a viable strategy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback